Nabis Corporate Presentation

ARIZONA - ONE OF THE LEADING MEDICAL CANNABIS MARKETS IN THE U.S. NABIS TM Nabis signed a definitive agreement to acquire full control of a licensed medical marijuana business in the State of Arizona*. ● CSE: NAB A licensed medical marijuana dispensary in Phoenix, in operation since 2015 with proprietary branded products including top-tier flower, vape pens, concentrates, edibles, tinctures and CBD products. Wholesale operations include an established distribution network serving more than 50% of the dispensaries in Arizona. Audited sales in 2017 of USD $7.4 million, sales in 2018 of USD $8.7 million. Nabis is currently evaluating 5-10 further investment opportunities across the full cannabis spectrum in Arizona *The purchase price is USD $7 million in cash, USD $2 million of common shares of Nabis ("Nabis Shares"), and USD $6 million deferred for 12 months, for an aggregate purchase price of USD $15 million for the Arizona assets. The Nabis Shares will be issuable upon closing of the Investment and the price per Nabis Share shall be calculated by reference to the 10-day volume weighted average price of the Company's shares on the Canadian Securities Exchange. 12

View entire presentation